Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP588650.RAATI_f79Dg_pBy0oTTCV_lL0t1ugWTX--ybLuSsNj924130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP588650.RAATI_f79Dg_pBy0oTTCV_lL0t1ugWTX--ybLuSsNj924130_assertion type Assertion NP588650.RAATI_f79Dg_pBy0oTTCV_lL0t1ugWTX--ybLuSsNj924130_head.
- NP588650.RAATI_f79Dg_pBy0oTTCV_lL0t1ugWTX--ybLuSsNj924130_assertion description "[These single gene transfection experiments have revealed that expression of Bcl-2 renders specific NBL cells resistant to chemotherapy-induced PCD and support the hypothesis that Bcl-2 enhances the malignant phenotype of NBL by promoting tumor resistance to chemotherapy agents.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP588650.RAATI_f79Dg_pBy0oTTCV_lL0t1ugWTX--ybLuSsNj924130_provenance.
- NP588650.RAATI_f79Dg_pBy0oTTCV_lL0t1ugWTX--ybLuSsNj924130_assertion evidence source_evidence_literature NP588650.RAATI_f79Dg_pBy0oTTCV_lL0t1ugWTX--ybLuSsNj924130_provenance.
- NP588650.RAATI_f79Dg_pBy0oTTCV_lL0t1ugWTX--ybLuSsNj924130_assertion SIO_000772 8205548 NP588650.RAATI_f79Dg_pBy0oTTCV_lL0t1ugWTX--ybLuSsNj924130_provenance.
- NP588650.RAATI_f79Dg_pBy0oTTCV_lL0t1ugWTX--ybLuSsNj924130_assertion wasDerivedFrom befree-20140225 NP588650.RAATI_f79Dg_pBy0oTTCV_lL0t1ugWTX--ybLuSsNj924130_provenance.
- NP588650.RAATI_f79Dg_pBy0oTTCV_lL0t1ugWTX--ybLuSsNj924130_assertion wasGeneratedBy ECO_0000203 NP588650.RAATI_f79Dg_pBy0oTTCV_lL0t1ugWTX--ybLuSsNj924130_provenance.